US Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences
- 1.0950
- -0.1150-9.50%
Trading Aug 28 13:54 ET
4.89MMarket Cap-1671P/E (TTM)
1.2600High1.0400Low75.69KVolume1.2600Open1.2100Pre Close87.00KTurnover2.38%Turnover RatioLossP/E (Static)4.46MShares2.390052wk High1.08P/B3.49MFloat Cap0.930052wk Low--Dividend TTM3.18MShs Float44.7500Historical High--Div YieldTTM18.18%Amplitude0.9300Historical Low1.1490Avg Price1Lot Size
Bright Minds Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -23.86%6.19M | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.97%6.75M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M | -41.15%11.63M | -41.15%11.63M |
| -Cash and cash equivalents | -23.86%6.19M | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.97%6.75M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M | -41.15%11.63M | -41.15%11.63M |
| Receivables | -83.38%17.24K | 1,558.27%553.25K | -24.02%45.04K | -76.26%36.98K | -76.26%36.98K | 7.51%103.68K | -83.99%33.36K | -60.40%59.28K | 41.43%155.78K | 41.43%155.78K |
| -Taxes receivable | -83.38%17.24K | -64.93%11.7K | -24.02%45.04K | -67.71%36.98K | -67.71%36.98K | 60.90%103.68K | -81.09%33.36K | -60.40%59.28K | 3.97%114.52K | 3.97%114.52K |
| -Other receivables | ---- | --541.55K | ---- | ---- | ---- | ---- | ---- | ---- | --41.26K | --41.26K |
| Prepaid assets | -58.86%58.32K | -91.44%15.31K | -79.72%32.07K | -83.16%27.69K | -83.16%27.69K | 76.53%141.74K | 110.01%178.84K | 11.26%158.16K | -2.25%164.43K | -2.25%164.43K |
| Total current assets | -25.19%6.27M | -34.23%6.5M | -40.16%6.84M | -42.98%6.81M | -42.98%6.81M | -5.01%8.38M | -15.96%9.88M | -25.84%11.43M | -40.37%11.95M | -40.37%11.95M |
| Non current assets | ||||||||||
| Net PPE | -85.71%12.08K | -70.59%30.19K | -60.00%48.3K | -52.17%66.41K | -52.17%66.41K | --84.53K | --102.64K | --120.75K | --138.86K | --138.86K |
| -Gross PPE | -85.71%12.08K | -70.59%30.19K | -60.00%48.3K | -52.17%66.41K | -52.17%66.41K | --84.53K | --102.64K | --120.75K | --138.86K | --138.86K |
| Total non current assets | -85.71%12.08K | -70.59%30.19K | -60.00%48.3K | -52.17%66.41K | -52.17%66.41K | 4,126.25%84.53K | 5,031.90%102.64K | 5,937.55%120.75K | 6,843.15%138.86K | 6,843.15%138.86K |
| Total assets | -25.80%6.28M | -34.60%6.53M | -40.37%6.89M | -43.09%6.88M | -43.09%6.88M | -4.07%8.46M | -15.10%9.99M | -25.06%11.55M | -39.69%12.09M | -39.69%12.09M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -76.75%149.61K | 223.07%801.06K | 148.19%799.6K | -85.37%182.31K | -85.37%182.31K | 66.98%643.4K | -75.08%247.95K | -33.24%322.17K | 108.92%1.25M | 108.92%1.25M |
| -accounts payable | -76.75%149.61K | 223.07%801.06K | 148.19%799.6K | -85.37%182.31K | -85.37%182.31K | 66.98%643.4K | -75.08%247.95K | -33.24%322.17K | 108.92%1.25M | 108.92%1.25M |
| Current accrued expenses | --15K | -98.54%10K | --0 | -84.19%25K | -84.19%25K | --0 | 7,764.92%684.25K | 1,843.00%136.01K | 276.61%158.18K | 276.61%158.18K |
| Current debt and capital lease obligation | -81.89%14.02K | -52.80%34.73K | -21.96%54.56K | 8.27%73.55K | 8.27%73.55K | --77.39K | --73.59K | --69.91K | --67.93K | --67.93K |
| -Current capital lease obligation | -81.89%14.02K | -52.80%34.73K | -21.96%54.56K | 8.27%73.55K | 8.27%73.55K | --77.39K | --73.59K | --69.91K | --67.93K | --67.93K |
| Current liabilities | -75.22%178.63K | -15.91%845.79K | 61.74%854.16K | -80.93%280.86K | -80.93%280.86K | 87.06%720.8K | 0.23%1.01M | 7.86%528.1K | 130.59%1.47M | 130.59%1.47M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | --0 | --0 | --14.02K | --34.73K | --54.56K | --71.98K | --71.98K |
| -Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | --14.02K | --34.73K | --54.56K | --71.98K | --71.98K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --14.02K | --34.73K | --54.56K | --71.98K | --71.98K |
| Total liabilities | -75.69%178.63K | -18.71%845.79K | 46.60%854.16K | -81.82%280.86K | -81.82%280.86K | 90.70%734.81K | 3.69%1.04M | 19.01%582.66K | 141.86%1.54M | 141.86%1.54M |
| Shareholders'equity | ||||||||||
| Share capital | 3.34%35.05M | 3.34%35.05M | 4.05%35.05M | 5.20%33.91M | 5.20%33.91M | 24.74%33.91M | 24.83%33.91M | 23.93%33.68M | 19.05%32.24M | 19.05%32.24M |
| -common stock | 3.34%35.05M | 3.34%35.05M | 4.05%35.05M | 5.20%33.91M | 5.20%33.91M | 24.74%33.91M | 24.83%33.91M | 23.93%33.68M | 19.05%32.24M | 19.05%32.24M |
| Retained earnings | -11.85%-33.58M | -18.36%-33.81M | -25.35%-33.23M | -30.50%-31.55M | -30.50%-31.55M | -41.51%-30.02M | -53.92%-28.56M | -88.44%-26.51M | -162.49%-24.17M | -162.49%-24.17M |
| Gains losses not affecting retained earnings | 26.60%3.8M | 30.83%3.61M | 14.24%3.39M | 37.09%3.4M | 37.09%3.4M | 22.54%3M | 28.54%2.76M | 60.50%2.96M | 58.43%2.48M | 58.43%2.48M |
| Other equity interest | 0.00%831.83K | 0.00%831.83K | 0.00%831.83K | --831.83K | --831.83K | 6,831.95%831.83K | --831.83K | 2,569.52%831.83K | ---- | ---- |
| Total stockholders'equity | -21.05%6.1M | -36.45%5.69M | -44.99%6.03M | -37.41%6.6M | -37.41%6.6M | -8.40%7.73M | -16.85%8.95M | -26.51%10.97M | -45.66%10.54M | -45.66%10.54M |
| Total equity | -21.05%6.1M | -36.45%5.69M | -44.99%6.03M | -37.41%6.6M | -37.41%6.6M | -8.40%7.73M | -16.85%8.95M | -26.51%10.97M | -45.66%10.54M | -45.66%10.54M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg